POS-100 OUTPATIENT PHARMACOLOGIC TREATMENTS FOR RAAS INHIBITOR-RELATED HYPERKALEMIA AND THE RISK OF RECURRENCE

Saved in:
Bibliographic Details
Published in:Kidney international reports 2021-04, Vol.6 (4), p.S41-S42
Main Authors: HUNDEMER, G., Talarico, R., Sood, M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S42
container_issue 4
container_start_page S41
container_title Kidney international reports
container_volume 6
creator HUNDEMER, G.
Talarico, R.
Sood, M.
description
doi_str_mv 10.1016/j.ekir.2021.03.108
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_00dc2a23a2934d488aedb060ace3b7f2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2468024921002540</els_id><doaj_id>oai_doaj_org_article_00dc2a23a2934d488aedb060ace3b7f2</doaj_id><sourcerecordid>S2468024921002540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2068-6bcc9004371a3a05d990f40c8efdacbdcf4e88b63c7e3934232ab54c60163c7a3</originalsourceid><addsrcrecordid>eNp9kV1PwjAUhhejiQT5A171DwzP2jG6xJs6ilv4GCnlwqum6zozRDAdMfHfW8AYr7xq8yTv03P6BsF9BMMIouRhO7RvrRtiwNEQiGf0KujhOKEh4Di9_nO_DQZdtwWAaJyMUqC9YL8q12EEgMqNXDFZ8KVEq5yJBcvKeflcZEgKzuTC8zWalgIJxtaoWObFUyFLEQo-Z5JPUP6y4mLG5nxRMMSWEyRzjkSxnqFyigTPNkLwZcbvgptG7zo7-Dn7wWbKZZaH57fYPDQY_KxJZUwKEJNxpImGUZ2m0MRgqG1qbaraNLGltEqIGVuSkhgTrKtRbBL_HZ5p0g-Ki7c-6K36cO27dl_qoFt1Bgf3qrQ7tmZnFUBtsMZEYy-qY0q1rStIQBtLqnGDvQtfXMYdus7Z5tcXgToVoLbqVIA6FaCAeEZ96PESsn7Lz9Y61ZnW7o2tW2fN0Y_R_hf_BsfvhRk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>POS-100 OUTPATIENT PHARMACOLOGIC TREATMENTS FOR RAAS INHIBITOR-RELATED HYPERKALEMIA AND THE RISK OF RECURRENCE</title><source>PubMed (Medline)</source><source>ScienceDirect Journals</source><creator>HUNDEMER, G. ; Talarico, R. ; Sood, M.</creator><creatorcontrib>HUNDEMER, G. ; Talarico, R. ; Sood, M.</creatorcontrib><identifier>ISSN: 2468-0249</identifier><identifier>EISSN: 2468-0249</identifier><identifier>DOI: 10.1016/j.ekir.2021.03.108</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Kidney international reports, 2021-04, Vol.6 (4), p.S41-S42</ispartof><rights>2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2468024921002540$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27898,27899,45753</link.rule.ids></links><search><creatorcontrib>HUNDEMER, G.</creatorcontrib><creatorcontrib>Talarico, R.</creatorcontrib><creatorcontrib>Sood, M.</creatorcontrib><title>POS-100 OUTPATIENT PHARMACOLOGIC TREATMENTS FOR RAAS INHIBITOR-RELATED HYPERKALEMIA AND THE RISK OF RECURRENCE</title><title>Kidney international reports</title><issn>2468-0249</issn><issn>2468-0249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kV1PwjAUhhejiQT5A171DwzP2jG6xJs6ilv4GCnlwqum6zozRDAdMfHfW8AYr7xq8yTv03P6BsF9BMMIouRhO7RvrRtiwNEQiGf0KujhOKEh4Di9_nO_DQZdtwWAaJyMUqC9YL8q12EEgMqNXDFZ8KVEq5yJBcvKeflcZEgKzuTC8zWalgIJxtaoWObFUyFLEQo-Z5JPUP6y4mLG5nxRMMSWEyRzjkSxnqFyigTPNkLwZcbvgptG7zo7-Dn7wWbKZZaH57fYPDQY_KxJZUwKEJNxpImGUZ2m0MRgqG1qbaraNLGltEqIGVuSkhgTrKtRbBL_HZ5p0g-Ki7c-6K36cO27dl_qoFt1Bgf3qrQ7tmZnFUBtsMZEYy-qY0q1rStIQBtLqnGDvQtfXMYdus7Z5tcXgToVoLbqVIA6FaCAeEZ96PESsn7Lz9Y61ZnW7o2tW2fN0Y_R_hf_BsfvhRk</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>HUNDEMER, G.</creator><creator>Talarico, R.</creator><creator>Sood, M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>202104</creationdate><title>POS-100 OUTPATIENT PHARMACOLOGIC TREATMENTS FOR RAAS INHIBITOR-RELATED HYPERKALEMIA AND THE RISK OF RECURRENCE</title><author>HUNDEMER, G. ; Talarico, R. ; Sood, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2068-6bcc9004371a3a05d990f40c8efdacbdcf4e88b63c7e3934232ab54c60163c7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HUNDEMER, G.</creatorcontrib><creatorcontrib>Talarico, R.</creatorcontrib><creatorcontrib>Sood, M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Kidney international reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HUNDEMER, G.</au><au>Talarico, R.</au><au>Sood, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>POS-100 OUTPATIENT PHARMACOLOGIC TREATMENTS FOR RAAS INHIBITOR-RELATED HYPERKALEMIA AND THE RISK OF RECURRENCE</atitle><jtitle>Kidney international reports</jtitle><date>2021-04</date><risdate>2021</risdate><volume>6</volume><issue>4</issue><spage>S41</spage><epage>S42</epage><pages>S41-S42</pages><issn>2468-0249</issn><eissn>2468-0249</eissn><pub>Elsevier Inc</pub><doi>10.1016/j.ekir.2021.03.108</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2468-0249
ispartof Kidney international reports, 2021-04, Vol.6 (4), p.S41-S42
issn 2468-0249
2468-0249
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_00dc2a23a2934d488aedb060ace3b7f2
source PubMed (Medline); ScienceDirect Journals
title POS-100 OUTPATIENT PHARMACOLOGIC TREATMENTS FOR RAAS INHIBITOR-RELATED HYPERKALEMIA AND THE RISK OF RECURRENCE
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-27T13%3A30%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=POS-100%20OUTPATIENT%20PHARMACOLOGIC%20TREATMENTS%20FOR%20RAAS%20INHIBITOR-RELATED%20HYPERKALEMIA%20AND%20THE%20RISK%20OF%20RECURRENCE&rft.jtitle=Kidney%20international%20reports&rft.au=HUNDEMER,%20G.&rft.date=2021-04&rft.volume=6&rft.issue=4&rft.spage=S41&rft.epage=S42&rft.pages=S41-S42&rft.issn=2468-0249&rft.eissn=2468-0249&rft_id=info:doi/10.1016/j.ekir.2021.03.108&rft_dat=%3Celsevier_doaj_%3ES2468024921002540%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2068-6bcc9004371a3a05d990f40c8efdacbdcf4e88b63c7e3934232ab54c60163c7a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true